Literature DB >> 31737329

Oncologic validity of minimally invasive lobectomy for early stage lung cancer.

Todd L Demmy1, Sai Yendamuri1.   

Abstract

Entities:  

Year:  2019        PMID： 31737329      PMCID： PMC6837994          DOI： 10.21037/jtd.2019.09.45

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  21 in total

1.  Prediction of Long-Term Survival After Lung Cancer Surgery for Elderly Patients in The Society of Thoracic Surgeons General Thoracic Surgery Database.

Authors:  Mark W Onaitis; Anthony P Furnary; Andrzej S Kosinski; Sunghee Kim; Daniel Boffa; Betty C Tong; Patricia Cowper; Jeffrey P Jacobs; Cameron D Wright; Joe B Putnam; Felix G Fernandez
Journal:  Ann Thorac Surg       Date:  2017-11-22       Impact factor: 4.330

Review 2.  Oncologic Equivalence of Minimally Invasive Lobectomy: The Scientific and Practical Arguments.

Authors:  Todd L Demmy; Sai Yendamuri; Thomas A D'Amico; William R Burfeind
Journal:  Ann Thorac Surg       Date:  2018-04-17       Impact factor: 4.330

3.  Optimal Approach to Lobectomy for Non-Small Cell Lung Cancer: Systemic Review and Meta-Analysis.

Authors:  Calvin S H Ng; John K MacDonald; Sebastien Gilbert; Ali Z Khan; Young T Kim; Brian E Louie; M Blair Marshall; Ricardo S Santos; Marco Scarci; Yaron Shargal; Hiran C Fernando
Journal:  Innovations (Phila)       Date:  2019-04

4.  Minimally Invasive Lobectomy Is Associated With Lower Noncancer-specific Mortality in Elderly Patients: A Propensity Score Matched Competing Risks Analysis.

Authors:  Boris Hristov; Takashi Eguchi; Sarina Bains; Joe Dycoco; Kay See Tan; James M Isbell; Bernard J Park; David R Jones; Prasad S Adusumilli
Journal:  Ann Surg       Date:  2019-12       Impact factor: 12.969

5.  Outcomes for Thoracoscopy Versus Thoracotomy Not Just Technique Dependent: A Study of 9,787 Patients.

Authors:  Andrea Wolf; Bian Liu; Emanuele Leoncini; Daniel Nicastri; Dong-Seok Lee; Emanuela Taioli; Raja Flores
Journal:  Ann Thorac Surg       Date:  2018-02-01       Impact factor: 4.330

6.  Favourable outcomes in patients with early-stage non-small-cell lung cancer operated on by video-assisted thoracoscopic surgery: a propensity score-matched analysis.

Authors:  Robert Dziedzic; Tomasz Marjanski; Franciszek Binczyk; Joanna Polanska; Wioletta Sawicka; Witold Rzyman
Journal:  Eur J Cardiothorac Surg       Date:  2018-09-01       Impact factor: 4.191

7.  Thoracoscopic Surgery Versus Thoracotomy for Lung Cancer: Short-Term Outcomes of a Randomized Trial.

Authors:  Hao Long; Qunyou Tan; Qingquan Luo; Zheng Wang; Gening Jiang; Dongrong Situ; Yongbin Lin; Xiaodong Su; Qing Liu; Tiehua Rong
Journal:  Ann Thorac Surg       Date:  2017-12-02       Impact factor: 4.330

8.  Robotic resection of Stage III lung cancer: an international retrospective study.

Authors:  Giulia Veronesi; Bernard Park; Robert Cerfolio; Mark Dylewski; Alpert Toker; Jacques P Fontaine; Wael C Hanna; Emanuela Morenghi; Pierluigi Novellis; Frank O Velez-Cubian; Marisa H Amaral; Elisa Dieci; Marco Alloisio; Eric M Toloza
Journal:  Eur J Cardiothorac Surg       Date:  2018-11-01       Impact factor: 4.191

9.  Video assisted thoracic surgery vs. thoracotomy for locally advanced lung squamous cell carcinoma after neoadjuvant chemotherapy.

Authors:  Likui Fang; Luming Wang; Yiqing Wang; Wang Lv; Jian Hu
Journal:  J Cardiothorac Surg       Date:  2018-12-17       Impact factor: 1.637

10.  Thoracoscopic lobectomy with mediastinal lymph node dissection as a standard surgery for T1-2N0M0 non-small cell lung cancer (>300 surgeries experience).

Authors:  Arif Allakhverdiev; Mikhail Davydov; Parvin Akhmedov
Journal:  Ann Med Surg (Lond)       Date:  2018-09-26
View more
  1 in total

Review 1.  Effect of operative approach on quality of life following anatomic lung cancer resection.

Authors:  Emily S Singer; Peter J Kneuertz; Jennifer Nishimura; Desmond M D'Souza; Ellen Diefenderfer; Susan D Moffatt-Bruce; Robert E Merritt
Journal:  J Thorac Dis       Date:  2020-11       Impact factor: 2.895
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.